160 related articles for article (PubMed ID: 12943952)
1. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.
Onder E; Tural U
J Affect Disord; 2003 Sep; 76(1-3):223-7. PubMed ID: 12943952
[TBL] [Abstract][Full Text] [Related]
2. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of buspirone and fluoxetine in short-term treatment of bulimia nervosa].
Rajewski A; Rybakowski F
Psychiatr Pol; 2006; 40(1):75-82. PubMed ID: 16756030
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine once every third day in the treatment of major depressive disorder.
Tural U; Onder E
Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
6. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
Perlis RH; Nierenberg AA; Alpert JE; Pava J; Matthews JD; Buchin J; Sickinger AH; Fava M
J Clin Psychopharmacol; 2002 Oct; 22(5):474-80. PubMed ID: 12352270
[TBL] [Abstract][Full Text] [Related]
7. Buspirone and imipramine for the treatment of major depression in the elderly.
Schweizer E; Rickels K; Hassman H; Garcia-España F
J Clin Psychiatry; 1998 Apr; 59(4):175-83. PubMed ID: 9590668
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.
Coppen A; Bailey J
J Affect Disord; 2000 Nov; 60(2):121-30. PubMed ID: 10967371
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
Rudolph RL; Feiger AD
J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.
Jangid P; Malik P; Singh P; Sharma M; Gulia AK
Asian J Psychiatr; 2013 Feb; 6(1):29-34. PubMed ID: 23380314
[TBL] [Abstract][Full Text] [Related]
11. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
Smith WT; Londborg PD; Glaudin V; Painter JR;
J Affect Disord; 2002 Aug; 70(3):251-9. PubMed ID: 12128237
[TBL] [Abstract][Full Text] [Related]
12. Possible augmentation of antidepressant response by buspirone.
Jacobsen FM
J Clin Psychiatry; 1991 May; 52(5):217-20. PubMed ID: 2033029
[TBL] [Abstract][Full Text] [Related]
13. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
14. Relationships among measures of treatment outcome in depressed patients.
Mulder RT; Joyce PR; Frampton C
J Affect Disord; 2003 Sep; 76(1-3):127-35. PubMed ID: 12943942
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Davidson JR; DuPont RL; Hedges D; Haskins JT
J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
[TBL] [Abstract][Full Text] [Related]
16. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Silverstone PH; Ravindran A
J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
[TBL] [Abstract][Full Text] [Related]
17. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
18. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
19. Predictors of an acute antidepressant response to fluoxetine and sertraline.
Flament MF; Lane RM; Zhu R; Ying Z
Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
[TBL] [Abstract][Full Text] [Related]
20. Buspirone augmentation of antidepressant therapy.
Dimitriou EC; Dimitriou CE
J Clin Psychopharmacol; 1998 Dec; 18(6):465-9. PubMed ID: 9864079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
